Fresh off the press.
People are talking about us.
Game-changing Rx decision will improve quality, cost, access, and transparency for CDPHP members, network providers, and small and large businesses.
Celebrating ambitious pioneers tackling our biggest challenges
In the News
Filter by News Type
Joshua Cohen sits down with Matthew Gibbs, President of Commercial Markets, to discuss why Capital Rx is the fastest growing PBM in the United States.
Check out Amber Meranda's interview with Built In on how to improve collaboration between product and customer success.
The health of a pharmacy business is under attack from many directions, but retail pharmacies can take steps to alleviate some of this pressure to improve the health of their business.
NADAC, which is being implemented by pharmacy benefit managers like Capital Rx helps develop better plans for their clients.
Together with his colleagues, Ryan Kelly, and Joseph Alexander, A.J. Loiacono founded a pharmacy benefit manager by the name of Capital Rx, which ensures greater transparency and more affordability for prescription drugs.
Capital Rx aims to cut out the middlemen and stakeholders from the drug pricing process, so that the full scope of pharmacy benefits can be experienced by patients.
People have become more aware of these practices, and they are willing to work with smaller and more transparent pharmacy benefit managers like Capital Rx, which is considered to be a leader in the movement for transparent drug pricing.
For decades, patients are forced to pay hefty prices for prescription drugs without getting any rebate or relief, even after having access to a comprehensive pharmacy benefits plan.
Although COVID-19 has drawn away the focus of the healthcare industry from other pressing matters, there are some issues that need to be addressed immediately, and the cost of prescription drugs is one of them.
We are excited to announce that we earned $50 million in funding, which will help us move our efforts forward.